marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-08-2022
Albireo Pharma Financial Statements 2011-2024 | ALBO
Annual Financial Statements Albireo Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
538 M | 700 M | 271 M | 284 M | 278 M | 39.7 M | 15.2 M | 32.7 M | 39.6 M | 30.7 M | 25.5 M |
Shares |
19.2 M | 19.1 M | 12.4 M | 11.7 M | 7.82 M | 2.13 M | 1.37 M | 713 K | 522 K | 363 K | 260 K |
Historical Prices |
28.5 | 36.7 | 22.7 | 26 | 35 | 19.6 | 7.5 | 45.3 | 81.6 | 81 | 74.4 |
Net Income |
-34 M | -108 M | -62.7 M | -46.1 M | -24.4 M | -13.8 M | -18.7 M | -14.1 M | -19.3 M | -20.7 M | -10.6 M |
Revenue |
40.6 M | 8.31 M | 9.64 M | 12.7 M | 1 K | - | - | - | - | - | - |
Cost of Revenue |
1.36 M | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
39.2 M | 8.31 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-123 M | -96.3 M | -61.1 M | -37.9 M | -24.6 M | -12.3 M | -4.73 M | - | - | - | - |
Interest Expense |
- | - | 3.69 M | -4.84 M | 40 K | -1.32 M | -1.72 M | - | - | - | - |
EBITDA |
-123 M | -96.1 M | -61 M | -37.8 M | -24.5 M | -13.9 M | -19.6 M | -18.7 M | -20 M | -18.6 M | -22.3 M |
Operating Expenses |
163 M | 105 M | 70.7 M | 50.6 M | 24.6 M | 14 M | 19.8 M | 19.3 M | 20.6 M | 19.3 M | 23.2 M |
General and Administrative Expenses |
69.6 M | 42.4 M | 23 M | 18.1 M | 15.2 M | 10.3 M | 6.4 M | 5.6 M | 6.84 M | 6.82 M | 9.32 M |
All numbers in USD currency
Quarterly Income Statement Albireo Pharma
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 19.7 M | 19.6 M | 19.4 M | 19.3 M | 19.3 M | 19.2 M | 19.1 M | 19.1 M | 15.7 M | 15 M | 14.1 M | 12.7 M | 12.7 M | 12.4 M | 12 M | 12 M | 12 M | 11.9 M | 10.9 M | 8.9 M | 8.88 M | 7.17 M | 6.29 M | 6.29 M | 303 K | 288 K | 266 K | 63.6 M | 33.9 M | 53.9 M | 24.4 M | 23.4 M | 21.1 M | 21.1 M | 23.4 M | 21.1 M | 19.6 M | 14.6 M | 21.1 M | 14.2 M | 14 M | 10.2 M | 14.2 M | 9.67 M | 9.66 M | 8.25 M | 6.62 M |
Net Income |
- | -37.8 M | -39.9 M | -42.4 M | - | 57.1 M | -36.4 M | -43.7 M | - | -30.7 M | -20.6 M | -31.5 M | - | -21.9 M | -16.6 M | -16.7 M | - | -14 M | -14.6 M | -1.62 M | - | -6.51 M | -6.18 M | -6.67 M | - | -4.03 M | 2.14 M | -3.24 M | -3.22 M | -15.5 M | -6.46 M | -4.36 M | -4.69 M | -11.8 M | -3.2 M | -4.69 M | -2.44 M | -815 K | -19.3 M | -2.44 M | -3.67 M | -5.88 M | -20.7 M | -3.67 M | -4.5 M | 4.13 M | -175 M | -4.5 M |
Revenue |
- | 9.83 M | 8.21 M | 6.83 M | - | 3.66 M | 2.43 M | 1.97 M | - | 2.13 M | 1.91 M | 1.55 M | - | 1.38 M | 1.25 M | 570 K | - | 237 K | 730 K | 11.2 M | - | 2 K | 1 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | 612 K | 776 K | 234 K | - | 431 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | 3.23 M | - | - | - | 2.13 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -34.7 M | -37.2 M | -39.6 M | - | -39.2 M | -33 M | -39.8 M | - | -27.1 M | -18.2 M | -29.6 M | - | -20.6 M | -15.3 M | -15.3 M | - | -12.7 M | -10.4 M | -581 K | - | -6.53 M | -6.61 M | -6.1 M | - | -3.44 M | 1.94 M | -2.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | -3.64 M | -2.39 M | -1.94 M | - | -1.27 M | -1.35 M | -1.31 M | - | -1.37 M | -1.67 M | -1.02 M | - | 23 K | -152 K | -249 K | - | -508 K | -512 K | -526 K | - | - | - | - | - | - | - | - | - | - | - | 78 K | - | - | - | 78 K | - | - | - | 78 K |
EBITDA |
- | -34.3 M | -37 M | -39.4 M | - | -39 M | -33 M | -39.7 M | - | -27 M | -18.1 M | -29.5 M | - | -20.5 M | -15.2 M | -15.3 M | - | -12.6 M | -10.4 M | -528 K | - | -6.51 M | -6.6 M | -6.09 M | - | -3.43 M | 1.95 M | -2.62 M | 30 K | 211 K | 164 K | - | 102 K | 462 K | 310 K | 102 K | 156 K | 484 K | 326 K | 156 K | 167 K | 555 K | 382 K | 167 K | 194 K | 732 K | 502 K | 194 K |
Operating Expenses |
- | - | - | - | - | 42.4 M | 35.5 M | 41.7 M | - | 29.2 M | 20.1 M | 31.1 M | - | 22 M | 16.5 M | 15.9 M | - | 12.9 M | 11.1 M | 11.8 M | - | 6.53 M | 6.61 M | 6.1 M | - | 3.47 M | 6.03 M | 2.75 M | 3.23 M | 16.3 M | 6.58 M | 4.53 M | 5.24 M | 15.6 M | 4.75 M | 5.24 M | 5.04 M | 16.2 M | 5.22 M | 5.04 M | 5.91 M | 13.6 M | 4.73 M | 5.91 M | 4.37 M | 18.6 M | 5.32 M | 4.37 M |
General and Administrative Expenses |
- | 20.6 M | 21.6 M | 16.9 M | - | 17.6 M | 16.9 M | 15.3 M | - | 11.7 M | 8.47 M | 8.15 M | - | 6.01 M | 5.48 M | 5.29 M | - | 3.85 M | 4.24 M | 4.13 M | - | 3.71 M | 3.71 M | 3.21 M | - | 1.35 M | 3.03 M | 1.31 M | 1.63 M | 4.97 M | 1.52 M | 1.61 M | 1.83 M | 4.48 M | 1.35 M | 1.83 M | 1.4 M | 5.37 M | 1.77 M | 1.4 M | 1.43 M | 5.63 M | 1.78 M | 1.37 M | 2.02 M | 7.26 M | 2.38 M | 2.02 M |
All numbers in USD currency